journal article·2020-02-28

Side-Chain-Dependent Binding of bis-Naphthalimide Self-Assembled Nanoparticles to G-Quadruplex DNA for Potential Anticancer Therapy

Goutam Kulsi, Annie Agnes Suganya Samson, Baskaran Purushothaman, Joon Myong Song

ACS Applied Nano Materials· Volume 3· Issue 2
Publisher page

Abstract

Novel bis-naphthalimide (NI)-based molecules composed of space linkers of phenyl dialkyne (bis-NI1 and bis-NI2), triazole (bis-NI3 and bis-NI4), and alkyne (bis-NI5 and bis-NI6) with the distinctive side chain of 2,6-diisopropylaniline or 2,4,6-trimethylaniline were designed and synthesized as nanoparticles (NPs) that bind to G-quadruplex (G4) DNA. The supramolecular assemblies of the bis-NIs were found to form isolated spheres (bis-NI1, bis-NI3), dumbbells with or without a cylindrical bridge (bis-NI2, bis-NI4), and needle-like structures (bis-NI6). The side chain of 2,4,6-trimethylaniline is suggested to play a key role in the self-assembly of the bridge-connected shape such as dumbbells or needle in bis-NIs with three different space linkers. The small sphere shaped NP formed by bis-NI1 displayed both intercalation and groove binding to G4-DNAs, while a larger sphere shaped NP of bis-NI3 represented binding to the G4-DNA groove. The dumbbells of bis-NI2 showed both intercalation and groove binding to G4-DNAs, whereas the dumbbells of bis-NI4 represented binding to the G4-DNA groove. The needle-shaped bis-NI6 exhibited both intercalation and groove binding to G4-DNAs. Different morphologies of self-assembled bis-NIs provided different IC50 values. Furthermore, bis-NI1, bis-NI4, and bis-NI6 induced cell cycle arrest (G1/S phase) and apoptosis in cancer cells. This suggests bis-NI1, bis-NI4, and bis-NI6 are potential anticancer agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: DNA and Nucleic Acid Chemistry · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, Seoul National University, Seoul 08826, South Korea

Funding

National Research Foundation of Korea

References (56)

Show source-provided references
1. 10.1093/nar/gkl65510.1093/nar/gkl655 ↗
2. 10.1073/pnas.86.18.704910.1073/pnas.86.18.7049 ↗
3. 10.1039/C4CC10030A10.1039/C4CC10030A ↗
4. 10.1039/b702491f10.1039/b702491f ↗
5. 10.1002/chem.20150517010.1002/chem.201505170 ↗
6. 10.1021/acs.bioconjchem.7b0078110.1021/acs.bioconjchem.7b00781 ↗
7. 10.1038/srep1369310.1038/srep13693 ↗
8. 10.1039/C4SC03949A10.1039/C4SC03949A ↗
9. 10.1039/C7SC02693E10.1039/C7SC02693E ↗
10. 10.1016/j.ejmech.2016.04.03010.1016/j.ejmech.2016.04.030 ↗
11. 10.1016/j.ejmech.2016.06.04010.1016/j.ejmech.2016.06.040 ↗
12. 10.1016/j.chempr.2018.02.01410.1016/j.chempr.2018.02.014 ↗
13. 10.1021/ja054309010.1021/ja0543090 ↗
14. 10.1021/ja062791w10.1021/ja062791w ↗
15. 10.1016/j.biochi.2008.03.00310.1016/j.biochi.2008.03.003 ↗
16. 10.1016/j.sbi.2009.04.00110.1016/j.sbi.2009.04.001 ↗
17. 10.1021/jp106683n10.1021/jp106683n ↗
18. 10.1016/j.biochi.2011.05.01210.1016/j.biochi.2011.05.012 ↗
19. 10.1002/chem.20180207710.1002/chem.201802077 ↗
20. 10.1016/j.ejmech.2018.10.01810.1016/j.ejmech.2018.10.018 ↗
21. 10.1016/j.ejmech.2018.09.05510.1016/j.ejmech.2018.09.055 ↗
22. 10.1039/C4DT02700K10.1039/C4DT02700K ↗
23. 10.1021/jm301899y10.1021/jm301899y ↗
24. 10.1039/c2ob06816h10.1039/c2ob06816h ↗
25. 10.1002/anie.20090636310.1002/anie.200906363 ↗
26. 10.1039/B606046N10.1039/B606046N ↗
27. 10.1016/j.cbpa.2005.10.00610.1016/j.cbpa.2005.10.006 ↗
28. 10.1021/acsomega.7b0125510.1021/acsomega.7b01255 ↗
29. 10.1016/j.chempr.2018.12.02410.1016/j.chempr.2018.12.024 ↗
30. 10.1002/anie.20170996810.1002/anie.201709968 ↗
31. 10.1021/jp509637y10.1021/jp509637y ↗
32. 10.1021/acs.organomet.8b0016610.1021/acs.organomet.8b00166 ↗
33. 10.1039/C6CC06176A10.1039/C6CC06176A ↗
34. 10.1039/C6RA12776B10.1039/C6RA12776B ↗
35. 10.1021/la503299j10.1021/la503299j ↗
36. 10.1080/1061027041233132883510.1080/10610270412331328835 ↗
37. 10.1002/chem.20080163710.1002/chem.200801637 ↗
38. 10.1039/b805242e10.1039/b805242e ↗
39. 10.1002/anie.20080488710.1002/anie.200804887 ↗
40. 10.1039/c2cs35467e10.1039/c2cs35467e ↗
41. 10.1016/j.bmcl.2018.01.00810.1016/j.bmcl.2018.01.008 ↗
42. 10.1039/C7NJ02366A10.1039/C7NJ02366A ↗
43. 10.1111/cbdd.1269810.1111/cbdd.12698 ↗
44. 10.1021/jm100025u10.1021/jm100025u ↗
45. 10.3390/molecules2302026610.3390/molecules23020266 ↗
46. 10.1039/C5MD00543D10.1039/C5MD00543D ↗
47. 10.1002/cbic.20050010110.1002/cbic.200500101 ↗
48. 10.1021/ja056406z10.1021/ja056406z ↗
49. 10.1039/b701444a10.1039/b701444a ↗
50. 10.1002/chem.20100293710.1002/chem.201002937 ↗
51. 10.1039/c1ob05884c10.1039/c1ob05884c ↗
52. 10.1016/j.jphotobiol.2013.03.01310.1016/j.jphotobiol.2013.03.013 ↗
53. 10.1021/jp910766q10.1021/jp910766q ↗
54. 10.1039/C7MD00389G10.1039/C7MD00389G ↗
55. 10.1038/s41598-017-04344-x10.1038/s41598-017-04344-x ↗
56. 10.1038/srep3923910.1038/srep39239 ↗